Currently, efforts in breast pathology have been focusing on breast cancer diagnosis and the detection of lymph node metastasis, quantitative analysis of ER, PR, HER2, Ki-67, TILs, mitotic count, and the evaluation of treatment response to neoadjuvant therapy (see review in [148]). Here, ERBB2 is linked to breast cancer.